Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Blockade in Laparoscopic Herniotomy
NCT02247466Phase 4Completed
- Sponsor
- Herlev Hospital
- Start
- Feb 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rocuronium in umbilical hernia, incisional hernia and epigastric hernia (2 arms), sponsored by Herlev Hospital. Primary endpoint: Improvement of Surgical Workspace at 3 hours. Started Feb 2015; status: completed.
02
Drugs
rocuronium
03
Conditions
umbilical herniaincisional herniaepigastric hernia
Beyond the preview
Go deeper on NCT02247466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247466.